Terms: = Lung cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Clinical Outcome
1 results:
1. TRIM46 activates AKT/hk2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells.
Tantai J; Pan X; Chen Y; Shen Y; Ji C
Cell Death Dis; 2022 Mar; 13(3):285. PubMed ID: 35354796
[TBL] [Abstract] [Full Text] [Related]
